Job ID: 6968BR
Job date: 2017-01-20
End Date:
Company : Illumina, Inc Country : Role : Research Scientist
Job date: 2017-01-20
End Date:
Company : Illumina, Inc Country : Role : Research Scientist
Job Description:
Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that inspires you, let’s talk. We’ve built a culture fueled by innovation, collaboration and openness, and established ourselves as the global leader in DNA sequencing and array-based technologies. Our people and our technology change lives by driving advancements in life sciences, oncology, reproductive health, agriculture and other emerging markets. We are deeply passionate about what we do, because we know that our work has the power to improve lives. The bioinformatics group within Illumina's Enterprise Informatics unit develops tools to efficiently transform sequencing data into actionable clinical findings and research insights. We are seeking an exceptional individual to help design and develop novel inference models and algorithmic transformations in the service of improved clinical decision making and health outcomes. Your responsibilities may include: -Designing statistical and machine-learning models to analyze sequencing data in the context of rare/undiagnosed disease and cancer. -High performance software/algorithm design and prototyping. -Analysis of error modes and actionable patterns in large-scale data sets. -Participation in clinical and population genomics research and methods development communities. Required Skills & Experience: -Ph.D. in computer science, statistics, bioinformatics, or related field of study. -Experience developing novel inference and/or machine-learning models. -Expertise in algorithms and software development using C++/C#/Java or similar. -Superior ability to present methods within the scientific community via publication, conference and personal communications. Preferences: -Training or research experience in genomics, population genetics or cancer. -Experience with next-generation sequencing platforms and data. -Exposure to professional software engineering development practices.
Additional Info:
All about us: Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $2.2 billion in 2015. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of February 2016, the company had a $21 billion market capitalization. EOE/Minorities/Females/Veterans/Disabled[Click Here to Access the Original Job Post]
Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that inspires you, let’s talk. We’ve built a culture fueled by innovation, collaboration and openness, and established ourselves as the global leader in DNA sequencing and array-based technologies. Our people and our technology change lives by driving advancements in life sciences, oncology, reproductive health, agriculture and other emerging markets. We are deeply passionate about what we do, because we know that our work has the power to improve lives. The bioinformatics group within Illumina's Enterprise Informatics unit develops tools to efficiently transform sequencing data into actionable clinical findings and research insights. We are seeking an exceptional individual to help design and develop novel inference models and algorithmic transformations in the service of improved clinical decision making and health outcomes. Your responsibilities may include: -Designing statistical and machine-learning models to analyze sequencing data in the context of rare/undiagnosed disease and cancer. -High performance software/algorithm design and prototyping. -Analysis of error modes and actionable patterns in large-scale data sets. -Participation in clinical and population genomics research and methods development communities. Required Skills & Experience: -Ph.D. in computer science, statistics, bioinformatics, or related field of study. -Experience developing novel inference and/or machine-learning models. -Expertise in algorithms and software development using C++/C#/Java or similar. -Superior ability to present methods within the scientific community via publication, conference and personal communications. Preferences: -Training or research experience in genomics, population genetics or cancer. -Experience with next-generation sequencing platforms and data. -Exposure to professional software engineering development practices.
Requeriments :
Skills :
- genomic
- HPC
- Machine Learning
- Next Generation Sequencing
- Population Genetics
- Programing in C
- Programing in C++
- Programming in C#
- Programming in Java
- Software Design
- Statistics
Areas :
Additional Info:
All about us: Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $2.2 billion in 2015. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of February 2016, the company had a $21 billion market capitalization. EOE/Minorities/Females/Veterans/Disabled[Click Here to Access the Original Job Post]